查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1439270

疼痛管理设备 - 全球市场回顾、竞争格局、市场预测 (2030)

Pain Management Devices - Market Insights, Competitive Landscape, and Market Forecast - 2030
出版日期: | 出版商: DelveInsight | 英文 150 Pages | 商品交期: 2-10个工作天内

价格

全球疼痛管理设备市场规模预计2023年将达到48.6亿美元，2030年将达到76.7亿美元，2024-2030年预测期间复合年增长率为7.90%。疼痛管理设备的需求主要由慢性疼痛盛行率上升、肌肉骨骼疾病高盛行率、人口老化迅速增加、人们对疼痛管理设备意识的快速提高以及创新产品的开发所推动。这是由研发投资增加和医疗保健成本上升推动的。

疼痛管理设备的市场动态

乳癌、肺癌和血癌等各种癌症的盛行率不断上升，是疼痛管理设备市场的主要驱动因素。例如，根据世界卫生组织（WHO）（2022）的数据，2020年乳癌病例为226万例，肺癌病例为221万例，大肠癌病例为193万例，摄护腺癌病例为141万例，据报道，胃癌109万例。神经性癌性疼痛 (NCP) 是由癌症本身引起的神经病变引起的，NCP 治疗对许多癌症患者无效。引入更好的疼痛管理设备可以减轻癌症患者的疼痛。

骨关节炎、类风湿性关节炎等骨科疾病盛行率的上升也是疼痛管理设备市场的关键驱动因素。根据世界卫生组织（WHO）（2022）的数据，肌肉骨骼疾病是导致残疾的主要原因，全球约有 17.1 亿人患有骨质疏鬆症、骨关节炎和类风湿性关节炎等肌肉骨骼疾病。

根据世界卫生组织（2022）的数据，2019 年全球约有 5.28 亿人患有骨关节炎。据同一消息来源称，2019 年全球有 1800 万人患有类风湿性关节炎。

骨关节炎，通常称为退化性关节炎或磨料性关节炎，会影响关节并最终磨损骨骼表面的光滑软骨。患者面临严重的疼痛、水肿和关节炎症，这限制了他们的活动自由。这就是为什么疼痛管理设备有助于治疗疼痛。

老年患者数量的增加预计将改变医疗保健服务并增加对更好生活方式的需求。根据最近的一项研究 "Global Population Aging 2020 Report" （联合国，2020），老年人口正以惊人的速度成长。2020年，全球65岁以上人口约为7.27亿人。到 2050 年，此类患者的数量预计将增加一倍，达到 15 亿。背痛、关节炎和慢性疼痛的病例随着年龄的增长而增加。老年患者需要疼痛管理设备来改善他们的生活方式。因此，所有这些因素预计将推动疼痛管理设备市场的成长。

公司在研发上花费大量资金来开发和推出创新产品。2019 年1月，Boston Scientific宣布推出一款先进的慢性疼痛管理设备，该设备被证实是市场上为数不多的能够结合麻木和亚感觉治疗的设备之一。预计这将提高该产品的知名度并增加对疼痛管理设备的需求。

然而，也存在限制疼痛管理设备采用的因素，例如过敏反应和术后感染，以及缺乏使用疼痛管理设备的最佳实践指南，这些因素也阻碍了疼痛的发展管理设备市场。马苏。

疼痛管理设备细分市场分析

就设备类型细分而言，神经调节和神经刺激设备预计将在疼痛管理设备市场中占据最大份额。这种增长可能是由于神经系统疾病的盛行率不断增加所致。

例如，根据癫痫中心2020年公布的数据，全球约有5,000万癫痫患者，每年约有240万个新诊断病例。此外，根据世界卫生组织（WHO）（2023）的数据，全球约有 5,000 万人患有失智症，每年新增近 1,000 万例。其中约 60-70% 是阿兹海默氏型失智症。因此，需要采取紧急措施来减轻这项负担。这些神经刺激装置在治疗慢性疼痛、帕金森氏症、癫痫、运动障碍和忧郁症方面发挥重要作用。这是由于神经刺激装置的成本效益、经皮神经电刺激（TENS）和脊髓刺激（SCS）装置在缓解慢性疼痛方面的高效性以及发达国家SCS治疗的报销潜力。可能性。

本报告提供了全球疼痛管理设备市场的研究和分析，包括市场规模和预测、驱动因素和挑战以及公司和产品概况。

目录

第1章 疼痛管理设备市场报告简介

第2章 疼痛管理设备市场执行摘要

  • 调查范围
  • 市场概况
  • 竞争评估

第3章 监管分析

  • 美国
  • 欧洲
  • 日本
  • 中国

第4章 疼痛管理设备市场关键因素分析

  • 疼痛管理设备市场驱动因素
    • 慢性疼痛的盛行率增加
    • 大众对疼痛管理设备的认识迅速提高
    • 加大研发投入，开发创新产品
    • 创新产品发布
    • 医疗费用增加
  • 疼痛管理设备市场的限制与挑战
    • 使用这些设备引起的过敏反应和术后感染限制了它们的采用。
    • 产品成本高
  • 疼痛管理设备市场机会
    • 新兴经济体尚未开发的潜力
    • 非医院环境中对疼痛管理设备的需求不断增长

第5章 疼痛管理装置的波特五力分析

第6章 疼痛管理器材市场布局

  • 按设备类型
    • 神经调节/神经刺激装置
    • 止痛输液泵
    • 消融装置
    • 其他
  • 按用途
    • 神经性疼痛
    • 癌症痛
    • 脸部疼痛/偏头痛
    • 肌肉骨骼疼痛
  • 按地区
    • 北美疼痛管理设备市场规模（2021-2030）
    • 欧洲疼痛管理设备市场规模（2021-2030）
    • 亚太地区疼痛管理设备市场规模（2021-2030）
    • 其他地区疼痛管理设备市场规模（2021-2030）

第7章：疼痛管理设备公司与产品简介

  • Abbott Laboratories
  • Baxter International Inc.
  • Boston Scientific Corporation
  • B Braun Melsungen AG
  • Nevro Corp.
  • Colfax Corporation
  • Omron Corporation
  • Koninklijke Philips NV
  • Smiths Medical
  • Medtronic plc.
  • Stryker Corporation
  • Stimwave LLC
  • Kimberly Clark Corporation
  • DJO Global LLC.
  • Aleva neurotherapeutics SA

第8章 KOL观点

第9章 专案方法

第10章 DelveInsight服务内容

第11章 关于 DelveInsight

第12章 免责声明与联络我们

Product Code: DIMDCL0060

Pain Management Devices Market By Type Of Devices (Neuromodulation and Neurostimulation Devices, Analgesic Infusion Pumps [Intrathecal Infusion Pumps and External Infusion Pumps], Ablation Devices [Radiofrequency Ablation Devices and Cryoablation Devices], and Others), Application (Neuropathic Pain, Cancer Pain, Facial & Migraine Pain, Musculoskeletal Pain, and Others), and Geography is expected to grow at a steady CAGR Forecast till 2030 owing to rise in prevalence of chronic pain and musculoskeletal disorders and surge in awareness among people toward pain management devices

The global pain management devices market was valued at USD 4.86 billion in 2023, growing at a CAGR of 7.90% during the forecast period from 2024 to 2030, to reach USD 7.67 billion by 2030. The demand for Pain Management Devices is primarily motivated by the rise in the prevalence of chronic pain, the high prevalence of musculoskeletal disorders, the surge in the geriatric population, the surge in awareness among people toward pain management devices, improved R&D investment to develop innovative products, and increasing cost of healthcare expenditure.

Pain Management Devices Market Dynamics:

The rising prevalence of different cancer types such as breast cancer, lung cancer, blood cancer, and others turns out to be an essential factor accelerating the pain management devices market. For instance, according to the data cited by the World Health Organization 2022, worldwide around 2.26 million cases of breast, 2.21 million cases of lung, 1.93 million cases of colon and rectum, 1.41 million cases of prostate, and 1.09 million cases of stomach cancer were reported in 2020. Neuropathic cancer pain (NCP) is caused by nerve damage attributable to cancer per se, and NCP management is ineffective in many cancer patients. With the introduction of better pain management devices, cancer patients may get relief from pain.

The rising prevalence of orthopedic diseases such as osteoarthritis, rheumatoid arthritis, and others is another important driver for the pain management devices market. According to World Health Organization (WHO) 2022, musculoskeletal conditions are the leading contributor to disability and worldwide around 1.71 billion people are suffering from musculoskeletal diseases such as osteoporosis, osteoarthritis, rheumatoid arthritis, and others.

According to WHO 2022, worldwide around 528 million people suffered from osteoarthritis in 2019. As per the same source, worldwide 18 million people had rheumatoid arthritis in 2019.

Osteoarthritis often referred to as degenerative or wear-and-tear arthritis affects the joints and eventually causes the smooth cartilage on the surface of the bones to wear away. Patients face significant pain, edema, and joint inflammation which limits their ability to move freely. Pain management devices are thereby helpful to treat pain.

It is predicted that the rising number of elderly patients would transform healthcare delivery and create a larger demand for a better lifestyle. As per the recent survey, Global Population Aging 2020 Report (United Nations, 2020), the aging population tends to grow at an alarming pace. In 2020, there were around 727 million individuals in the world aged 65 years or older. By 2050, the figure of such patients is expected to double and reach 1.5 billion by 2050. The cases of lower back pain, arthritis, and chronic pain increase with age. Older age patients require pain management devices to improve their living style. Thus, all these factors are projected to drive the growth of the market for pain management devices.

Companies are spending more on research and development for developing and launching innovative products. In January 2019, Boston Scientific announced the launch of an advanced chronic pain management device, which has been identified as one of the very few devices in the market with the ability to combine paresthesia and sub-perception therapy. This is expected to increase awareness about the product and boost the demand for pain management devices.

Certain factors such as hypersensitivity reactions and post-operative infections caused due to the use of these devices limit their adoption the pain management devices and also non-availability of best practice guidelines for using pain management devices poses a minor hurdle for the growth of the pain management devices market.

Pain Management Devices Segment Analysis:

By Type of Devices (Neuromodulation and Neurostimulation Devices, Analgesic Infusion Pumps [Intrathecal Infusion Pumps and External Infusion Pumps], Ablation Devices [Radiofrequency Ablation Devices and Cryoablation Devices], and Others), Application (Neuropathic Pain, Cancer Pain, Facial & Migraine Pain, Musculoskeletal Pain, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World).

In the type of devices segment, neuromodulation, and neurostimulation devices are expected to hold the largest share in the pain management devices market. The growth can be attributed to the increased prevalence of neurological disorders.

For instance, around 50 million patients are living with epilepsy worldwide, and around 2.4 million new cases are diagnosed annually, as per the data published by the Epilepsy Centre in 2020. Furthermore, According to World Health Organisation (2023) data, globally, around 50 million people have dementia, and there are nearly 10 million new cases every year. Around 60-70% of these cases are of Alzheimer's. Urgent measures to reduce this burden are therefore needed. These neurostimulators play a crucial role in treating chronic pain, Parkinson's disease, epilepsy, movement disorders, and depression. This can be due to the cost-effectiveness of neurostimulation devices, the high efficacy of transcutaneous electrical nerve stimulation (TENS) and spinal cord stimulation (SCS) devices in alleviating chronic pain, and the availability of reimbursement for SCS therapy in developed countries

Moreover, the approval of various neurostimulation devices for the treatment of chronic pain is also expected to surge segment growth.

For instance, in September 2020, Nerivio®, a smartphone-controlled electroceutical device developed by Theranica Bioelectronics for the acute treatment of episodic or chronic migraine in adolescents received CE mark approval.

Further, key market players indulge in research and development for the development of neuromodulation and neurostimulation devices for the treatment of chronic pain could also augment the market.

Recently on January 21, 2021, Saluda Medical Pty Limited announced the positive data from multiple studies evaluating the company's Evoke® ECAP-Controlled, Closed-Loop Spinal Cord Stimulation (SCS) System for the treatment of chronic pain.

Hence, all the aforementioned factors will contribute to the segmental growth of the pain management devices market.

North America is expected to dominate the overall Pain Management Devices Market:

North America is expected to dominate the overall pain management devices market during the forecast period. The growing prevalence of chronic pain in the region is anticipated to boost the demand for pain management devices during the forecasted period.

For instance, as per the data published in the year 2021 by the Centers for Disease Control and Prevention (CDC), it has been estimated that there will be around 78.4 million people suffering from doctor-diagnosed arthritis by 2040, and out of that two-thirds will be the women population.

As per the same source, an estimated 34.6 million adults will face arthritis-attributable activity limitations in the US by 2040. Arthritis is linked with pain in joints. There are many drug-free options for patient to consider, such as TENS, such as device TENS therapy by Omron Health.

Additionally, recent product approval and launches by the companies actively manufacturing devices for pain management will also contribute to the market growth.

For instance, in June 2021, NeuraLace announced FDA 510(k) clearance and the US Launch of Axon Therapy® Peripheral Nerve Stimulation System for chronic pain relief.

Moreover, increasing government initiatives, such as the Precision Medicine and Affordable Care Act, along with a well-planned reimbursement scenario in this region is contributing to market growth.

Thus, all the above-mentioned factors will lead to an increase in the United States pain management devices market growth during the forecasting period of 2024-2030.

Pain Management Devices Market Key Players:

Some of the key market players operating in the pain management devices market include Smiths Medical, B. Braun Melsungen AG, Baxter, Boston Scientific Corp., Colfax Corp., Medtronic Plc, Nevro Corp., Abbott, Stryker, Omron Healthcare, Inc., Stimwave LLC, and others.

Recent Developmental Activities in the Pain Management Devices Market:

In July 2022, Nevro Corp. received FDA approval for its Senza® System for the treatment of chronic pain associated with Painful Diabetic Neuropathy (PDN).

In July 2022, Unity HA received Breakthrough Device Designation by FDA for the Pulsante® SPG Microstimulator System for the treatment of acute pain associated with chronic cluster headaches.

In May 2022, SoftWave Tissue Regeneration Technologies patented extracorporeal shock wave device called the OrthGold 100® was cleared by the FDA, for the indications of a temporary increase in local blood circulation, relief of minor aches and pains, and activation of connective tissue.

Key Takes Away from the Pain Management Devices Market Report Study

Market size analysis for current market size (2023), and market forecast for 5 years (2024-2030)

Top key product/services/technology developments, mergers, acquisitions, partnerships, and joint ventures happened for the last 3 years

Key companies dominating the global pain management devices market.

Various opportunities available for the other competitor in the pain management devices market space.

What are the top-performing segments in 2023? How these segments will perform in 2030?

Which are the top-performing regions and countries in the current market scenario?

Which are the regions and countries where companies should have concentrated on opportunities for market growth in the coming future?

Target Audience who can be benefited from This Pain Management Devices Market Report Study

Pain Management Devices providers

Research organizations and consulting companies

Pain Management Devices-related organization, association, forum, and other alliances

Government and corporate offices

Start-up companies, venture capitalists, and private equity firms

Distributors and Traders

Various End-Users who want to know more about the pain management devices market and the latest technological developments in the pain management devices market.

Frequently Asked Questions for the Pain Management Devices Market:

1. What are Pain Management Devices?

Pain management devices are medical devices that are used in management of different types of pain such as neuropathic pain, cancer pain, nociceptive pain, musculoskeletal pain, and others.

2. What is the market for global pain management devices?

The global pain management devices market was valued at USD 4.86 billion in 2023, growing at a CAGR of 7.90% during the forecast period from 2024 to 2030, to reach USD 7.67 billion by 2030.

3. What are the drivers for the pain management devices market?

The major drivers driving the demand for pain management devices are the increase in the prevalence of chronic pain, the high prevalence of musculoskeletal disorders, the surge in the geriatric population, the surge in awareness among people toward pain management devices, and the growing cost of healthcare expenditure.

4. Who are the key players operating in the global pain management devices market?

Some of the key market players operating in the pain management devices market include Smiths Medical, B. Braun Melsungen AG, Baxter, Boston Scientific Corp., Colfax Corp., Medtronic Plc, Nevro Corp., Abbott, Stryker, Omron Healthcare, Inc., Stimwave LLC and others.

5. Which region has the highest share in the pain management devices market?

North America is expected to dominate the overall pain management devices market during the forecast period, 2024 to 2030. this domination is due to the growing demand for advance technologies, the increasing chronic disease in the region, and the high adoption of technological advancements owing to the rise in healthcare expenditure by the US government.

Table of Contents

1. Pain Management Devices Market Report Introduction

2. Pain Management Devices Market Executive Summary

  • 2.1. Scope of the Study
  • 2.2. Market at Glance
  • 2.3. Competitive Assessment

3. Regulatory Analysis

  • 3.1. The United States
  • 3.2. Europe
  • 3.3. Japan
  • 3.4. China

4. Pain Management Devices Market Key Factors Analysis

  • 4.1. Pain Management Devices Market Drivers
    • 4.1.1. Rise in prevalence of chronic pain
    • 4.1.2. Surge in awareness among people toward pain management devices
    • 4.1.3. Improved R&D investment to develop innovative products
    • 4.1.4. Launch of innovative products
    • 4.1.5. Increasing cost of healthcare
  • 4.2. Pain Management Devices Market Restraints and Challenges
    • 4.2.1. Hypersensitivity reactions and post-operative infections caused due to use of these devices limit their adoption
    • 4.2.2. High Cost of product
  • 4.3. Pain Management Devices Market Opportunities
    • 4.3.1. Untapped potential offered by developing economies
    • 4.3.2. Growing demand for Pain Management Devices in non-hospital settings

5. Pain Management Devices Porter's Five Forces Analysis

  • 5.1. Bargaining Power of Suppliers
  • 5.2. Bargaining Power of Consumers
  • 5.3. Threat of New Entrants
  • 5.4. Threat of Substitutes
  • 5.5. Competitive Rivalry

6. Pain Management Devices Market Layout

  • 6.1. By Type of Devices
    • 6.1.1. Neuromodulation & Neurostimulation Devices
    • 6.1.2. Analgesic Infusion Pumps
      • 6.1.2.1. Intrathecal Infusion Pumps
      • 6.1.2.2. External Infusion Pumps
    • 6.1.3. Ablation Devices
      • 6.1.3.1. Radiofrequency Ablation Devices
      • 6.1.3.2. Cryoablation Devices
    • 6.1.4. Others
  • 6.2. By Application
    • 6.2.1. Neuropathic Pain
    • 6.2.2. Cancer Pain
    • 6.2.3. Facial & Migraine Pain
    • 6.2.4. Musculoskeletal Pain
    • 6.2.5. Others
  • 6.3. By Geography
    • 6.3.1. North America Pain Management Devices Market Size in USD million (2021-2030)
      • 6.3.1.1. United States Pain Management Devices Market Size in USD million (2021-2030)
      • 6.3.1.2. Canada Pain Management Devices Market Size in USD million (2021-2030)
      • 6.3.1.3. Mexico Pain Management Devices Market Size in USD million (2021-2030)
    • 6.3.2. Europe Pain Management Devices Market Size in USD million (2021-2030)
      • 6.3.2.1. France Pain Management Devices Market Size in USD million (2021-2030)
      • 6.3.2.2. Germany Pain Management Devices Market Size in USD million (2021-2030)
      • 6.3.2.3. United Kingdom Pain Management Devices Market Size in USD million (2021-2030)
      • 6.3.2.4. Italy Pain Management Devices Market Size in USD million (2021-2030)
      • 6.3.2.5. Spain Pain Management Devices Market Size in USD million (2021-2030)
      • 6.3.2.6. Rest of Europe Pain Management Devices Market Size in USD million (2021-2030)
    • 6.3.3. Asia-Pacific Pain Management Devices Market Size in USD million (2021-2030)
      • 6.3.3.1. China Pain Management Devices Market Size in USD million (2021-2030)
      • 6.3.3.2. Japan Pain Management Devices Market Size in USD million (2021-2030)
      • 6.3.3.3. India Pain Management Devices Market Size in USD million (2021-2030)
      • 6.3.3.4. Australia Pain Management Devices Market Size in USD million (2021-2030)
      • 6.3.3.5. South Korea Pain Management Devices Market Size in USD million (2021-2030)
      • 6.3.3.6. Rest of Asia Pacific Pain Management Devices Market Size in USD million (2021-2030)
    • 6.3.4. Rest of the World (RoW) Pain Management Devices Market Size in USD million (2021-2030)
      • 6.3.4.1. Middle East Pain Management Devices Market Size in USD million (2021-2030)
      • 6.3.4.2. Africa Pain Management Devices Market Size in USD million (2021-2030)
      • 6.3.4.3. South America Pain Management Devices Market Size in USD million (2021-2030)

7. Pain Management Devices Company and Product Profiles

  • 7.1. Abbott Laboratories
    • 7.1.1. Company Overview
    • 7.1.2. Company Snapshot
    • 7.1.3. Financial Overview
    • 7.1.4. Product Listing
    • 7.1.5. Entropy
  • 7.2. Baxter International Inc.
    • 7.2.1. Company Overview
    • 7.2.2. Company Snapshot
    • 7.2.3. Financial Overview
    • 7.2.4. Product Listing
    • 7.2.5. Entropy
  • 7.3. Boston Scientific Corporation
    • 7.3.1. Company Overview
    • 7.3.2. Company Snapshot
    • 7.3.3. Financial Overview
    • 7.3.4. Product Listing
    • 7.3.5. Entropy
  • 7.4. B Braun Melsungen AG
    • 7.4.1. Company Overview
    • 7.4.2. Company Snapshot
    • 7.4.3. Financial Overview
    • 7.4.4. Product Listing
    • 7.4.5. Entropy
  • 7.5. Nevro Corp.
    • 7.5.1. Company Overview
    • 7.5.2. Company Snapshot
    • 7.5.3. Financial Overview
    • 7.5.4. Product Listing
    • 7.5.5. Entropy
  • 7.6. Colfax Corporation
    • 7.6.1. Company Overview
    • 7.6.2. Company Snapshot
    • 7.6.3. Financial Overview
    • 7.6.4. Product Listing
    • 7.6.5. Entropy
  • 7.7. Omron Corporation
    • 7.7.1. Company Overview
    • 7.7.2. Company Snapshot
    • 7.7.3. Financial Overview
    • 7.7.4. Product Listing
    • 7.7.5. Entropy
  • 7.8. Koninklijke Philips NV
    • 7.8.1. Company Overview
    • 7.8.2. Company Snapshot
    • 7.8.3. Financial Overview
    • 7.8.4. Product Listing
    • 7.8.5. Entropy
  • 7.9. Smiths Medical
    • 7.9.1. Company Overview
    • 7.9.2. Company Snapshot
    • 7.9.3. Financial Overview
    • 7.9.4. Product Listing
    • 7.9.5. Entropy
  • 7.10. Medtronic plc.
    • 7.10.1. Company Overview
    • 7.10.2. Company Snapshot
    • 7.10.3. Financial Overview
    • 7.10.4. Product Listing
    • 7.10.5. Entropy
  • 7.11. Stryker Corporation
    • 7.11.1. Company Overview
    • 7.11.2. Company Snapshot
    • 7.11.3. Financial Overview
    • 7.11.4. Product Listing
    • 7.11.5. Entropy
  • 7.12. Stimwave LLC
    • 7.12.1. Company Overview
    • 7.12.2. Company Snapshot
    • 7.12.3. Financial Overview
    • 7.12.4. Product Listing
    • 7.12.5. Entropy
  • 7.13. Kimberly Clark Corporation
    • 7.13.1. Company Overview
    • 7.13.2. Company Snapshot
    • 7.13.3. Financial Overview
    • 7.13.4. Product Listing
    • 7.13.5. Entropy
  • 7.14. DJO Global LLC.
    • 7.14.1. Company Overview
    • 7.14.2. Company Snapshot
    • 7.14.3. Financial Overview
    • 7.14.4. Product Listing
    • 7.14.5. Entropy
  • 7.15. Aleva neurotherapeutics SA
    • 7.15.1. Company Overview
    • 7.15.2. Company Snapshot
    • 7.15.3. Financial Overview
    • 7.15.4. Product Listing
    • 7.15.5. Entropy

8. KOL Views

9. Project Approach

10. DelveInsight Capabilities

11. About DelveInsight

12. Disclaimer & Contact Us

List of Tables

  • Table 1: Competitive Analysis
  • Table 2: Pain Management Devices Market in Global (2021-2030)
  • Table 3: Pain Management Devices Market in Global by Type of Devices (2021-2030)
  • Table 4: Pain Management Devices Market in Global by Application (2021-2030)
  • Table 5: Pain Management Devices Market in Global by Geography (2021-2030)
  • Table 6: Pain Management Devices Market in North America (2021-2030)
  • Table 7: Pain Management Devices Market in the US (2021-2030)
  • Table 8: Pain Management Devices Market in Canada (2021-2030)
  • Table 9: Pain Management Devices Market in Mexico (2021-2030)
  • Table 10: Pain Management Devices Market in Europe (2021-2030)
  • Table 11: Pain Management Devices Market in France (2021-2030)
  • Table 12: Pain Management Devices Market in Germany (2021-2030)
  • Table 13: Pain Management Devices Market in the United Kingdom (2021-2030)
  • Table 14: Pain Management Devices Market in Italy (2021-2030)
  • Table 15: Pain Management Devices Market in Spain (2021-2030)
  • Table 16: Pain Management Devices Market in Rest of Europe (2021-2030)
  • Table 17: Pain Management Devices Market in Asia-Pacific (2021-2030)
  • Table 18: Pain Management Devices Market in China (2021-2030)
  • Table 19: Pain Management Devices Market in Japan (2021-2030)
  • Table 20: Pain Management Devices Market in India (2021-2030)
  • Table 21: Pain Management Devices Market in Australia (2021-2030)
  • Table 22: Pain Management Devices Market in South Korea (2021-2030)
  • Table 23: Pain Management Devices Market in Rest of Asia-Pacific (2021-2030)
  • Table 24: Pain Management Devices Market in the Rest of the World (2021-2030)
  • Table 25: Pain Management Devices Market in the Middle East (2021-2030)
  • Table 26: Pain Management Devices Market in Africa (2021-2030)
  • Table 27: Pain Management Devices Market in South America (2021-2030)

List of Figures

  • Figure 1: Competitive Analysis
  • Figure 2: Pain Management Devices Market in Global (2021-2030)
  • Figure 3: Pain Management Devices Market in Global by Type of Devices (2021-2030)
  • Figure 4: Pain Management Devices Market in Global by Application (2021-2030)
  • Figure 5: Pain Management Devices Market in Global by Geography (2021-2030)
  • Figure 6: Pain Management Devices Market in North America (2021-2030)
  • Figure 7: Pain Management Devices Market in the US (2021-2030)
  • Figure 8: Pain Management Devices Market in Canada (2021-2030)
  • Figure 9: Pain Management Devices Market in Mexico (2021-2030)
  • Figure 10: Pain Management Devices Market in Europe (2021-2030)
  • Figure 11: Pain Management Devices Market in France (2021-2030)
  • Figure 12: Pain Management Devices Market in Germany (2021-2030)
  • Figure 13: Pain Management Devices Market in the Kingdom (2021-2030)
  • Figure 14: Pain Management Devices Market in Italy (2021-2030)
  • Figure 15: Pain Management Devices Market in Spain (2021-2030)
  • Figure 16: Pain Management Devices Market in Rest of Europe (2021-2030)
  • Figure 17: Pain Management Devices Market in Asia-Pacific (2021-2030)
  • Figure 18: Pain Management Devices Market in China (2021-2030)
  • Figure 19: Pain Management Devices Market in Japan (2021-2030)
  • Figure 20: Pain Management Devices Market in India (2021-2030)
  • Figure 21: Pain Management Devices Market in Australia (2021-2030)
  • Figure 22: Pain Management Devices Market in South Korea (2021-2030)
  • Figure 23: Pain Management Devices Market in Rest of Asia Pacific (2021-2030)
  • Figure 24: Pain Management Devices Market in the Rest of the World (2021-2030)
  • Figure 25: Pain Management Devices Market in the Middle East (2021-2030)
  • Figure 26: Pain Management Devices Market in Africa (2021-2030)
  • Figure 27: Pain Management Devices Market in South America (2021-2030)
  • Figure 28: Market Drivers
  • Figure 29: Market Barriers
  • Figure 30: Market Opportunities